SCHEMBL514162

SCHEMBL514162

CC[CH]OC(=O)Nc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.51
▸ SMN1; SMN2 Q16637 6/20 0.49
▸ HPGD P15428 2/20 0.49
▸ NPC1 O15118 4/20 0.47
▸ CRHBP P24387 1/20 0.47
▸ CRHR2 Q13324 1/20 0.47
▸ GAA P10253 4/20 0.47
▸ HTT P42858 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ NAPRT Q6XQN6 1/20 0.47
▸ MAPT P10636 3/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ TSHR P16473 2/20 0.46
▸ TP53 P04637 1/20 0.45
▸ EPHX1 P07099 1/20 0.45
▸ EPHX2 P34913 1/20 0.45
▸ CDK9 P50750 1/20 0.45
▸ CLK4 Q9HAZ1 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL4046449 0.79 SMN1; SMN2 (0.62) RAB9ASMN1; SMN2HPGDNPC1CRHBP
SCHEMBL482921 0.79 NAPRT (0.52) RAB9ASMN1; SMN2HPGDNPC1GAA
SCHEMBL282531 0.78 SMN1; SMN2 (0.71) RAB9ASMN1; SMN2HPGDNPC1GAA
SCHEMBL28219382 0.77 SMN1; SMN2 (0.52) RAB9ASMN1; SMN2HPGDNPC1GAA
SCHEMBL8884482 0.77 SMN1; SMN2 (0.69) RAB9ASMN1; SMN2HPGDNPC1GAA
Acetaldehyde SCHEMBL4039985 0.76 SMN1; SMN2 (0.62) RAB9ASMN1; SMN2HPGDNPC1GAA
Ethyl Phenylcarbamate SCHEMBL264865 0.76 RAB9A (0.75) RAB9ASMN1; SMN2HPGDNPC1CRHBP
SCHEMBL4153167 0.76 TGM2 (0.57) RAB9ASMN1; SMN2HPGDNPC1GAA
Ethyl Phenylcarbamate SCHEMBL11593824 0.76 RAB9A (0.75) RAB9ASMN1; SMN2HPGDNPC1CRHBP
Ethyl Phenylcarbamate SCHEMBL21059180 0.75 RAB9A (0.69) RAB9ASMN1; SMN2HPGDNPC1CRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0450039-A1 DIHYDRO-1,2 OXO-2 QUINOXALINE DERIVATES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS. FABRE PIERRE COSMETIQUE (FR) 1991-10-09 — — EP claimed
WO-2023210623-A1 HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME 株式会社エス・ディー・エス バイオテック 2023-11-02 — — WO disclosed
WO-2014184071-A1 MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES SYNGENTA LIMITED (GB) 2014-11-20 — — WO disclosed
WO-2014184070-A1 MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES SYNGENTA LIMITED (GB) 2014-11-20 — — WO disclosed
EP-2420493-A1 HALOALKYLSULFONANILIDE DERIVATIVE Nissan Chemical Industries, Ltd. (JP) 2012-02-22 — — EP disclosed
US-20120029187-A1 HALOALKYLSULFONANILIDE DERIVATIVE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-02-02 — — US disclosed
EP-2336104-A1 ORTHO-SUBSTITUTED HALOALKYLSULFONANILIDE DERIVATIVE AND HERBICIDE Nissan Chemical Industries, Ltd. (JP) 2011-06-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029187-A1 HALOALKYLSULFONANILIDE DERIVATIVE CBR3, CBR1, HDHD5 RAB9A 223/4885SMN1; SMN2 4115/4885HPGD 3162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback